Reply to BIRB-796 is not an effective ABL(T315I) inhibitor

Authors :: Daniel K. Treiber
Patrick P. Zarrinkar
Miles A. Fabian
David J. Lockhart
William H. Biggs
Source :: Nature Biotechnology. 23:1210-1211
Publication Year :: 2005
Publisher :: Springer Science and Business Media LLC, 2005.

Subjects :: ABL
Chemistry
Biomedical Engineering
Cancer research
Molecular Medicine
Bioengineering
Applied Microbiology and Biotechnology
Biotechnology

Tools